STOCK TITAN

Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Phathom Pharmaceuticals (Nasdaq: PHAT) announced management will attend three investor conferences in March 2026: TD Cowen (Boston) on March 2, Jefferies Biotech on the Beach (Miami) on March 10, and Barclays Global Healthcare (Miami) on March 11.

The company will host a March 2 presentation at 10:30 am EST and a March 11 fireside chat at 3:30 pm EDT, and management will hold one-on-one meetings. Webcasts and archived recordings will be available on the investor News & Events page and remain accessible for 90 days.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – PHAT

-0.44%
1 alert
-0.44% News Effect

On the day this news was published, PHAT declined 0.44%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

FLORHAM PARK, N.J., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, announced today that members of its management team are scheduled to participate in the following upcoming investor conferences in March:

TD Cowen 46th Annual Health Care Conference in Boston, MA
Date: Monday, March 2, 2026
Company Presentation: 10:30 am EST
Management to participate in one-on-one meetings throughout the conference

Jefferies Biotech on the Beach Summit in Miami, FL
Date: Tuesday, March 10, 2026
Management to participate in one-on-one meetings throughout the conference

Barclays 28th Annual Global Healthcare Conference in Miami, FL
Date: Wednesday, March 11, 2026
Fireside Chat: 3:30 pm EDT
Management to participate in one-on-one meetings throughout the conference

To access the live webcast and archived recordings of each event, visit the News & Events section of the Phathom website at https://investors.phathompharma.com/news-events/events-and-presentations. Recordings will be available for 90 days following the conclusion of each meeting.

About Phathom Pharmaceuticals, Inc.
Phathom Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of novel treatments for gastrointestinal diseases. Phathom has in-licensed the exclusive rights to vonoprazan, a first-in-class potassium-competitive acid blocker (PCAB), for the U.S., Europe and Canada. Phathom currently markets vonoprazan in the United States as VOQUEZNA® (vonoprazan) tablets for the relief of heartburn associated with Non-Erosive GERD in adults, the healing and maintenance of healing of Erosive GERD in adults and relief of associated heartburn, and as part of VOQUEZNA® TRIPLE PAK® (vonoprazan tablets, amoxicillin capsules, clarithromycin tablets) and VOQUEZNA® DUAL PAK® (vonoprazan tablets, amoxicillin capsules) for the treatment of H. pylori infection in adults. For more information about Phathom, visit the company’s website at www.phathompharma.com and follow on LinkedIn and X.

MEDIA CONTACT
Nick Benedetto
1-877-742-8466
media@phathompharma.com

INVESTOR CONTACT
Eric Sciorilli
1-877-742-8466
ir@phathompharma.com

© 2026 Phathom Pharmaceuticals. All rights reserved. VOQUEZNA, VOQUEZNA DUAL PAK, VOQUEZNA TRIPLE PAK, Phathom Pharmaceuticals, and their respective logos are registered trademarks of Phathom Pharmaceuticals, Inc.


FAQ

When will Phathom Pharmaceuticals (PHAT) present at TD Cowen in March 2026?

Phathom will present at TD Cowen on Monday, March 2, 2026 at 10:30 am EST. According to the company, management will present that morning and participate in one-on-one investor meetings throughout the conference, with a live webcast available on the investor site.

What events will Phathom (PHAT) attend in Miami in March 2026?

Phathom plans to attend Jefferies Biotech on the Beach on March 10 and Barclays Global Healthcare on March 11, 2026. According to the company, management will hold one-on-one meetings at both events and will appear in a Barclays fireside chat at 3:30 pm EDT.

How can investors access Phathom (PHAT) webcasts and recordings from the March 2026 conferences?

Investors can access live webcasts and archived recordings via the Phathom investor News & Events page. According to the company, recordings will be posted on the site and remain available for 90 days following each meeting.

Will Phathom (PHAT) management hold one-on-one meetings at the March 2026 conferences?

Yes, Phathom management will participate in one-on-one meetings throughout each listed conference. According to the company, these meetings will occur at TD Cowen, Jefferies Biotech on the Beach, and Barclays Global Healthcare during the March 2026 events.

What time is Phathom's (PHAT) Barclays fireside chat on March 11, 2026?

Phathom's Barclays fireside chat is scheduled for Wednesday, March 11, 2026 at 3:30 pm EDT. According to the company, management will also take part in one-on-one investor meetings during the Barclays Global Healthcare conference in Miami.
Phathom Pharmaceuticals, Inc.

NASDAQ:PHAT

PHAT Rankings

PHAT Latest News

PHAT Latest SEC Filings

PHAT Stock Data

890.91M
61.40M
Biotechnology
Pharmaceutical Preparations
Link
United States
FLORHAM PARK